| CAPTOR THERAPEUTICS |
| Polen |
| Gesundheit |
| PLCPTRT00014 / A3CNAX |
| 60Q (Frankfurt) |
| FRA:60Q, ETR:60Q, 60Q:GR |
| - |
| http://www.captortherapeu.. |
|
Captor Therapeutics S.A. is an innovative biotechnology company specializing in the development of targeted protein degradation technologies aimed at treating serious medical conditions. Its primary function is to address diseases that do not respond..
>Volltext.. |
| 104.71 Mio. EUR |
| 97.18 Mio. EUR |
| 1.8 Mio. EUR |
| -11.24 Mio. EUR |
| -9.69 Mio. EUR |
| -1.76 EUR |
| 0.91 Mio. EUR |
| 0.93 Mio. EUR |
| -1.77 Mio. EUR |
| 3.93 |
| -60.74% |
| 0.69% |
| - |
| - |
| - |
| - |
| CAPTOR THERAPEUTICS, CAPTOR THERAPEUTIC |
| 04.04.26 |
|